Medicaid expansion and provision of prescription contraception to Medicaid beneficiaries

Contraception. 2021 Mar;103(3):199-202. doi: 10.1016/j.contraception.2020.11.005. Epub 2020 Nov 17.

Abstract

Introduction: Medicaid expansion increased access to care, but longitudinal patterns of contraception use after the Medicaid expansion have not been described.

Methods: We evaluated the effects of Medicaid expansion on the amount and type of contraceptive prescriptions using the Medicaid State Utilization Dataset.

Results: Overall long-acting reversible contraception (LARC) use increased in both expansion and non-expansion states. In a difference-in-differences analysis, states that expanded Medicaid had no appreciable increase in per-capita prescription rates of LARC (p = 0.26) or short-acting hormonal contraception (p = 0.09) when compared to nonexpansion states.

Discussion: The Medicaid expansion was not associated with a change in per-capita LARC or short-acting hormonal contraception use.

Keywords: Access to care; Contraception; Health policy; Medicaid expansion; Prevention; Women's health.

MeSH terms

  • Contraception
  • Humans
  • Long-Acting Reversible Contraception*
  • Medicaid*
  • Prescriptions
  • United States